The Michel Sadelain Lab

View All Featured News

View All Publications

m-sadelain@ski.mskcc.org

Email Address

212-639-6190

Office Phone

Members

Lab Alumni

Lab Affiliations

• Immunology Program
• Department of Medicine
• Center for Experimental Therapeutics
• Center for Cell Engineering

Achievements

• Awarded Breakthrough Prize in Life Sciences (2024)
• Citation Laureate 2023
• Recipient of the American Society of Gene & Cell Therapy Outstanding Achievement Award (2021)
• Laureate of the 48th Foundation ARC Léopold Griffuel award for translational and clinical research, Paris, France (2020)
• Inserm International Prize, Paris, France (2019)

Read more

• Jacob and Louise Gabbay Award in Biotechnology and Medicine (2019)
• Pasteur Weizmann/Servier Prize at the Academy of Sciences in Paris (2018)
• Passano Award Laureate, Johns Hopkins University (2018)
• Academy of Sciences Medal, Institut de France, Paris, France (2018)
• Elected to Vice President of the American Society for Gene and Cell Therapy (Vice President 2013, President Elect 2014, President 2015)
• Inventor of the Year Award, New York Intellectual Property Law Association (NYIPLA) (2014)
• Cited in Science magazine "Breakthrough of the Year: Cancer Immunology” (2013)
• Sultan Bin Khalifa International Thalassemia Awards (SITA) International Award for Innovative Medical Research on Thalassemia (2013)
• Antonio Cao Award for Research in Thalassemia or Hemoglobinopathies, Palermo, Italy (2013)
• Recipient of the Coley Award of the Cancer Research Institute for Distinguished Research in Tumor Immunology (shared with Carl June, University of Pennsylvania) (2012)
• Member, Grant Review Committee and Strategic Committee, CIRM (2011)
• Incumbent of the Stephen and Barbara Friedman Chair (2007)
• V Foundation Award in Honor of Mayor Rudolph Guliani (2005)

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michel Sadelain discloses the following relationships and financial interests:

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

---

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.

View all disclosures